Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

NEUROFIBROMATOSIS NETWORK

Filed by VAN SCOYOC ASSOCIATES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 17, 2026
Income
$20,000.00
Expenses
Not reported
Filing UUID
bc3cfac2-88c6-4218-adfc-47728d311248
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Medical research issues and Neurofibromatosis provisions, as follows: H.R.9495, Department of Defense Appropriations Act, 2027 H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Literal federal measure citations: H.R.9495, H.R.9260

DEF · Defense

H.R.9495, Department of Defense Appropriations Act, 2027, Medical research issues and Neurofibromatosis provisions

Literal federal measure citations: H.R.9495

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.